Anatara Lifesciences Ltd (ANR) - Cash Flow Conversion Efficiency

Latest as of June 2025: -2.561x

Based on the latest financial reports, Anatara Lifesciences Ltd (ANR) has a cash flow conversion efficiency ratio of -2.561x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.37 Million ≈ $-971.13K USD) by net assets (AU$535.97K ≈ $379.23K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Anatara Lifesciences Ltd balance sheet independence to measure how much of total assets are equity-financed.

Anatara Lifesciences Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Anatara Lifesciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Anatara Lifesciences Ltd (ANR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Anatara Lifesciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anatara Lifesciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Freight Technologies Inc NASDAQ:FRGT	0.134x
Lord Resources Ltd AU:LRD	-0.660x
Goldcliff Resource Corp V:GCN	0.001x
AnalytixInsight Inc V:ALY	-0.001x
Northcliff Citranusa Indonesia Tbk PT JK:SKYB	-0.062x
Australian Bond Exchange Holdings Ltd AU:ABE	0.350x
Fram Skandinavien AB Series B ST:FRAM-B	-3.021x
Beeks Trading Corporation Ltd LSE:BKS	0.143x

Annual Cash Flow Conversion Efficiency for Anatara Lifesciences Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Anatara Lifesciences Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Anatara Lifesciences Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$535.97K ≈ $379.23K	AU$-2.27 Million ≈ $-1.61 Million	-4.239x	-363.73%
2024-06-30	AU$1.36 Million ≈ $965.52K	AU$-1.25 Million ≈ $-882.61K	-0.914x	+62.57%
2023-06-30	AU$924.54K ≈ $654.17K	AU$-2.26 Million ≈ $-1.60 Million	-2.442x	-49.22%
2022-06-30	AU$1.36 Million ≈ $965.33K	AU$-2.23 Million ≈ $-1.58 Million	-1.637x	-198.86%
2021-06-30	AU$3.83 Million ≈ $2.71 Million	AU$-2.10 Million ≈ $-1.48 Million	-0.548x	+42.59%
2020-06-30	AU$2.86 Million ≈ $2.02 Million	AU$-2.72 Million ≈ $-1.93 Million	-0.954x	-152.17%
2019-06-30	AU$5.92 Million ≈ $4.19 Million	AU$-2.24 Million ≈ $-1.58 Million	-0.378x	+2.02%
2018-06-30	AU$8.59 Million ≈ $6.08 Million	AU$-3.32 Million ≈ $-2.35 Million	-0.386x	-61.22%
2017-06-30	AU$12.02 Million ≈ $8.51 Million	AU$-2.88 Million ≈ $-2.04 Million	-0.239x	-1050.92%
2016-06-30	AU$13.48 Million ≈ $9.53 Million	AU$-280.37K ≈ $-198.38K	-0.021x	+94.08%
2015-06-30	AU$5.48 Million ≈ $3.88 Million	AU$-1.92 Million ≈ $-1.36 Million	-0.351x	-296.93%
2014-06-30	AU$7.23 Million ≈ $5.11 Million	AU$-639.27K ≈ $-452.32K	-0.088x	-114.01%
2013-06-30	AU$-280.65K ≈ $-198.58K	AU$-177.22K ≈ $-125.39K	0.631x	--

About Anatara Lifesciences Ltd

AU:ANR Australia Biotechnology

Market Cap

$1.75 Million

AU$2.47 Million AUD

Market Cap Rank

#30124 Global

#1765 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$1.64